Deadline submission abstract: 14 March 2011
Deadline submission poster: 15 April 2011
Presentation of poster: 26 April 2011
Venue: Geneva, Switzerland
Biovision and the Global Alliance for Alternatives to DDT are calling for posters on innovative products, methods or strategies to DDT used for malaria vector control. The purpose of this poster award is to honour and to encourage innovative alternatives to DDT.
This poster event gives researchers, malaria professionals and people involved in community-based activities the opportunity to present new, innovative and original means for malaria vector control. It will be an avenue to use synergies, to create dialogue and to stimulate new partnerships. Posters will be examined by a competent selection committee, and an “Innovation Grant” is allocated to the winning submission(s) to further develop, deploy or disseminate the respective product, method or strategy.
Submissions should propose a specific product, method or a strategy for malaria vector control to address one or several of the four goals of the Global Alliance:
Goal 1: Strengthen the base of knowledge available to inform policy formulation and decision making
Goal 2: Overcome the complexity and cost of deploying alternatives to DDT
Goal 3: Make available new alternative vector control chemicals
Goal 4: Develop non-chemical products and approaches for vector control
Who can apply? Individuals, organisations and companies that are developing, deploying or disseminating alternative products, methods or strategies to DDT for malaria vector control. The applicant must be already or become a member of the Global Alliance of the Stockholm Convention. A form to become member is available here.
April 26, 2011: The poster session takes place during the Fifth Meeting of the Conference of the Parties to the Stockholm Convention (COP-5) and the award ceremony will be held during 1st Assembly of the “Global Alliance for Alternatives to DDT”. Place: Centre Internationale de Conférences (CICG), Geneva, Switzerland (Location of COP-5)
Interested parties please read the attachment below, complete the application form and send it before March 14, 2011 to Stefanie Keller, Project Officer, Biovision, s.keller@biovision.ch. Applicants will be notified until March 21 on acceptance of their submission.

Comments
direction
i think we all forget that Malaria is the end result of a mosquito bite. vaccines and treatments are now comming but in the Africa i live in it fails to reach all.
we work with stopping the bite and have succeded in designing a product, but because it deals with the wrong end of scientific research we cannot get funding. after fifteen years we have a product approved and tested but the market will never see it because the product is not injected or injested.
the world needs to wake up that the mozzi is a serious pest even when it does not bite, so deal with the pest and the reduction in bite follows.
malcolm
biotechnics1@yahoo.com